Access Now: Eight Steps to Your Eight Figure Fortune
Here is the latest financial fact sheet of Cipla. For more details, see the Cipla quarterly results and Cipla share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | -0.2 |
No. of shares | m | 806.08 |
% ch week | % | -6.9 |
% ch 1-mth | % | -5.7 |
% ch 12-mth | % | 83.5 |
52 week H/L | Rs | 878.6/356.8 |
No. of Mths Year Ending |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
5-Yr Chart Click to enlarge
|
---|
CIPLA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 748 | 622 | 663 | 678 | 586 | |
Low | Rs | 495 | 458 | 479 | 484 | 357 | |
Sales per share (Unadj.) | Rs | 171.7 | 181.9 | 183.2 | 198.2 | 207.0 | |
Earnings per share (Unadj.) | Rs | 17.2 | 12.9 | 17.6 | 18.5 | 18.6 | |
Diluted earnings per share | Rs | 17.2 | 12.8 | 17.6 | 18.5 | 18.6 | |
Cash flow per share (Unadj.) | Rs | 26.6 | 29.3 | 34.0 | 35.0 | 33.2 | |
Dividends per share (Unadj.) | Rs | 2.00 | 2.00 | 3.00 | 3.00 | 4.00 | |
Adj. dividends per share | Rs | 1.99 | 2.00 | 3.00 | 3.00 | 4.00 | |
Dividend yield (eoy) | % | 0.3 | 0.4 | 0.5 | 0.5 | 0.8 | |
Book value per share (Unadj.) | Rs | 143.3 | 155.9 | 176.7 | 186.3 | 195.5 | |
Adj. book value per share | Rs | 142.9 | 155.6 | 176.5 | 186.2 | 195.6 | |
Shares outstanding (eoy) | m | 803.38 | 804.51 | 805.12 | 805.70 | 806.35 | |
Bonus/Rights/Conversions | ESOP | ESOP | ESOP | ESOP | ESOS | ||
Price / Sales ratio | x | 3.6 | 3.0 | 3.1 | 2.9 | 2.3 | |
Avg P/E ratio | x | 36.1 | 42.0 | 32.5 | 31.4 | 25.3 | |
P/CF ratio (eoy) | x | 23.4 | 18.4 | 16.8 | 16.6 | 14.2 | |
Price / Book Value ratio | x | 4.3 | 3.5 | 3.2 | 3.1 | 2.4 | |
Dividend payout | % | 11.6 | 15.5 | 17.1 | 16.2 | 21.5 | |
Avg Mkt Cap | Rs m | 499,381 | 434,516 | 459,724 | 468,031 | 379,912 | |
No. of employees | `000 | 24.1 | 23.0 | 23.6 | 22.6 | 25.8 | |
Total wages/salary | Rs m | 24,340 | 26,338 | 26,901 | 28,565 | 30,270 | |
Avg. sales/employee | Rs Th | 5,723.7 | 6,349.1 | 6,247.7 | 7,053.1 | 6,459.6 | |
Avg. wages/employee | Rs Th | 1,010.3 | 1,143.0 | 1,139.4 | 1,261.5 | 1,171.2 | |
Avg. net profit/employee | Rs Th | 574.2 | 449.3 | 600.0 | 659.1 | 580.2 |
CIPLA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 137,901 | 146,302 | 147,509 | 159,710 | 166,949 | |
Other income | Rs m | 2,082 | 2,287 | 3,577 | 4,766 | 3,442 | |
Total revenues | Rs m | 139,983 | 148,589 | 151,085 | 164,475 | 170,391 | |
Gross profit | Rs m | 24,797 | 24,758 | 28,264 | 30,973 | 32,060 | |
Depreciation | Rs m | 7,542 | 13,229 | 13,228 | 13,263 | 11,747 | |
Interest | Rs m | 2,066 | 1,594 | 1,142 | 1,684 | 1,974 | |
Profit before tax | Rs m | 17,270 | 12,222 | 17,470 | 20,791 | 21,782 | |
Minority Interest | Rs m | 0 | 0 | -28 | -172 | -475 | |
Prior Period Items | Rs m | -120 | -70 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | -775 | 0 | 0 | |
Tax | Rs m | 3,316 | 1,798 | 2,501 | 5,695 | 6,312 | |
Profit after tax | Rs m | 13,834 | 10,354 | 14,166 | 14,924 | 14,995 | |
Gross profit margin | % | 18.0 | 16.9 | 19.2 | 19.4 | 19.2 | |
Effective tax rate | % | 19.2 | 14.7 | 14.3 | 27.4 | 29.0 | |
Net profit margin | % | 10.0 | 7.1 | 9.6 | 9.3 | 9.0 |
CIPLA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 88,412 | 87,356 | 108,141 | 124,266 | 117,038 | |
Current liabilities | Rs m | 77,761 | 33,737 | 38,322 | 37,715 | 43,931 | |
Net working cap to sales | % | 7.7 | 36.6 | 47.3 | 54.2 | 43.8 | |
Current ratio | x | 1.1 | 2.6 | 2.8 | 3.3 | 2.7 | |
Inventory Days | Days | 101 | 87 | 100 | 91 | 96 | |
Debtors Days | Days | 62 | 64 | 77 | 95 | 85 | |
Net fixed assets | Rs m | 110,786 | 111,567 | 109,411 | 105,190 | 107,424 | |
Share capital | Rs m | 1,607 | 1,609 | 1,610 | 1,611 | 1,613 | |
"Free" reserves | Rs m | 113,555 | 123,828 | 140,682 | 148,511 | 156,018 | |
Net worth | Rs m | 115,162 | 125,437 | 142,292 | 150,123 | 157,630 | |
Long term debt | Rs m | 2,219 | 36,454 | 36,621 | 38,301 | 23,693 | |
Total assets | Rs m | 211,282 | 210,371 | 228,606 | 239,633 | 236,626 | |
Interest coverage | x | 9.4 | 8.7 | 16.3 | 13.3 | 12.0 | |
Debt to equity ratio | x | 0 | 0.3 | 0.3 | 0.3 | 0.2 | |
Sales to assets ratio | x | 0.7 | 0.7 | 0.6 | 0.7 | 0.7 | |
Return on assets | % | 7.5 | 5.7 | 6.7 | 6.9 | 7.2 | |
Return on equity | % | 12.0 | 8.3 | 10.0 | 9.9 | 9.5 | |
Return on capital | % | 16.4 | 8.5 | 10.0 | 11.8 | 12.8 | |
Exports to sales | % | 48.5 | 34.2 | 33.8 | 34.7 | 33.0 | |
Imports to sales | % | 12.5 | 8.3 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 66,837 | 50,050 | 49,883 | 55,419 | 55,175 | |
Imports (cif) | Rs m | 17,270 | 12,203 | 0 | 0 | 0 | |
Fx inflow | Rs m | 67,461 | 51,066 | 51,691 | 57,410 | 56,036 | |
Fx outflow | Rs m | 24,729 | 17,678 | 21,033 | 19,041 | 6,764 | |
Net fx | Rs m | 42,733 | 33,388 | 30,658 | 38,368 | 49,272 |
CIPLA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 17,408 | 23,818 | 14,628 | 16,911 | 30,685 | |
From Investments | Rs m | -45,226 | -13,102 | -8,540 | -16,687 | 1,040 | |
From Financial Activity | Rs m | 31,041 | -13,257 | -3,855 | -3,487 | -29,488 | |
Net Cashflow | Rs m | 3,123 | -2,478 | 2,431 | -3,451 | 2,340 |
Share Holding
|
Company Information
|
CHM: Y. K. Hamied (MD) | COMP SEC: Mital Sanghvi | YEAR OF INC: 1935 | BSE CODE: 500087 | FV (Rs): 2 | DIV YIELD (%): 0.5 |
Read: CIPLA 2019-20 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: NEULAND LABS IPCA LABS DR. REDDYS LAB PIRAMAL ENTERPRISES INDRAPRASTHA MEDICAL
Compare CIPLA With: NEULAND LABS IPCA LABS DR. REDDYS LAB PIRAMAL ENTERPRISES INDRAPRASTHA MEDICAL
Compare CIPLA With: ACTAVIS (US) MYLAN (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Indian share markets witnessed huge buying interest during the extended closing hours today and ended their day on a strong note.
For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.
Here's an analysis of the annual report of CIPLA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.
For the quarter ended June 2020, CIPLA has posted a net profit of Rs 6 bn (up 21.4% YoY). Sales on the other hand came in at Rs 43 bn (up 7.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.
Here's an analysis of the annual report of CIPLA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.
More Views on NewsIn this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.
This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.
A look at what India's top equity mutual funds bought and sold in January 2021.
Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
More